KCNJ3 and breast cancer: In summary, Ab#1 yielded satisfactory results regarding specificity and sensitivity, and the protocol was further optimised for archived human FFPE breast cancer samples using patient sample #2 with high KCNJ3 mRNA expression levels (according to microarray data; table 1) as biological positive control (see online supplementary file 4 for details).